Breast Cancer :: Lack of care for older breast cancer patients
Older women with breast cancer get a lower level of care than younger women, researchers at the University of Manchester have found.
Older women with breast cancer get a lower level of care than younger women, researchers at the University of Manchester have found.
In classic movies, cigarette smoking was used as shorthand to convey sultriness and beauty. In the real world, the connection between smoking and one?s appearance ? as many studies have shown ? has more to do with premature signs of aging and less to do with glamour and refinement.
Most postmenopausal women with small breast tumors don?t need chemotherapy to reduce their recurrence risk after lumpectomy.
Postmenopausal women without symptoms of cardiovascular problems who have minor or major abnormalities on an electrocardiogram are at increased risk for future cardiovascular events and death, according to a study in the March 7 issue of JAMA.
Women who regularly engage in strenuous physical activity may have a lower risk of developing both invasive breast cancer and in situ (early-stage) breast cancer than women who do not, according to a report in the Feb. 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Philadelphia Jury returns verdict that Wyeth’s hormone replacement therapy caused breast cancer and awards $3 million to Ohio woman and her husband.
Wyeth (NYSE: WYE) announced today that the jury in the case of Jennie Nelson v. Wyeth, in the Philadelphia Court of Common Pleas, found in favor of the plaintiffs and awarded damages of $3 million. Wyeth plans to appeal.
Health care professionals should focus on women’s lifetime heart disease risk, not just short-term risk, according to updated American Heart Association guidelines.
Two critical characteristics of breast cancer that are important to treatment can be identified by measuring gene expression in the tumor, a research team led by scientists at the University of Texas M. D. Anderson Cancer Center reports in Lancet Oncology online.
Aromatase inhibitors, a type of hormone therapy used to treat advanced breast cancer in postmenopausal women, result in a small but significant increase in overall survival when compared to other hormone treatments, according to a new systematic review of studies.